Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice

被引：1
|
作者：
Beasley, Richard [1 ,2 ]
Harper, James [1 ]
Masoli, Matthew [3 ]
机构：
[1] Med Res Inst New Zealand, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Wellington, New Zealand
[3] Univ Exeter, Royal Devon & Exeter Hosp, Exeter, Devon, England
来源：
LANCET RESPIRATORY MEDICINE | 2020年 / 8卷 / 05期
关键词：
BENRALIZUMAB; ANTIBODY; SAFETY;
D O I：
10.1016/S2213-2600(20)30051-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：425 / 427
页数：4
相关论文
共 50 条
  • [1] Anti-interleukin-5 therapy in severe asthma
    Garcia, Gilles
    Taille, Camille
    Laveneziana, Pierantonio
    Bourdin, Arnaud
    Chanez, Pascal
    Humbert, Marc
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (129): : 251 - 257
  • [2] Anti-Interleukin-5 Therapy and Severe Asthma REPLY
    Pavord, Ian D.
    Wardlaw, Andrew J.
    Haldar, Pranabashis
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24): : 2577 - 2577
  • [3] Demographic and Clinical Characteristics of Asthma Patients with Anti-Interleukin-5 Therapy in the Sentinel Distributed Database
    Li, Y.
    Fazio-Eynullayeva, E.
    Bradley, M.
    Chen, J.
    Chin, S.
    DeLuccia, S.
    Eworuke, E.
    Freitas, K.
    Maro, J. C.
    Panozzo, C. A.
    Ren, Y.
    Zhang, R.
    Sahajwalla, C.
    Martin, D.
    Seymour, S.
    Quinto, K.
    Busch, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Improved small airway dysfunction in severe asthma with clinical remission by anti-interleukin-5/interleukin-5 receptor α
    Akamatsu, Taisuke
    Shirai, Toshihiro
    Okawa, Kohei
    Hirai, Keita
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (05) : 648 - 650
  • [5] Anti-interleukin-5 antibody therapy in asthma and allerges
    Corren, Jonathan
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (06) : 565 - 570
  • [6] A retrospective review of clinical outcomes in patients switched from Omalizumab to Anti-interleukin-5 therapy in a regional asthma specialist centre
    O'Reilly, Emily
    Casey, Deborah
    McGrath, Alice
    McHugh, Tomas
    Vairamani, Punitha
    Murphy, James
    Plant, Barry
    Murphy, Desmond
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (SUPPL 5) : 188 - 188
  • [7] Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome
    Kay, AB
    Klion, AD
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (04) : 645 - +
  • [8] Is this a death knell for anti-interleukin-5 therapy in asthma?
    Phillip Lieberman
    Current Allergy and Asthma Reports, 2009, 9 (1)
  • [9] Anti-Interleukin-5 Therapy Is Associated with Attenuated Lung Function Decline in Severe Eosinophilic Asthma Patients From the Belgian Severe Asthma Registry
    Graff, Sophie
    Brusselle, Guy
    Hanon, Shane
    Sohy, Carine
    Dupont, Lieven
    Peche, Rudy
    Michils, Alain
    Pilette, Charles
    Joos, Guy
    Lahousse, Lies
    Lapperre, Therese
    Louis, Renaud
    Schleich, Florence
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 467 - 477
  • [10] Is This a Death Knell for Anti-interleukin-5 Therapy in Asthma?
    Flood-Page, P.
    Swenson, C.
    Faiferman, I
    CURRENT ALLERGY AND ASTHMA REPORTS, 2009, 9 (01) : 41 - 42
12345